- Home
- PCRX vs CYH Comparison
PCRX vs CYH Comparison
Compare PCRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- CYH
- Stock Information
- Founded
- PCRX 2006
- CYH 1985
- Country
- PCRX United States
- CYH United States
- Employees
- PCRX N/A
- CYH N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- PCRX Health Care
- CYH Health Care
- Exchange
- PCRX Nasdaq
- CYH Nasdaq
- Market Cap
- PCRX 1.2B
- CYH 482.7M
- IPO Year
- PCRX 2011
- CYH 1991
- Fundamental
- Price
- PCRX $22.73
- CYH $3.66
- Analyst Decision
- PCRX Buy
- CYH Hold
- Analyst Count
- PCRX 8
- CYH 8
- Target Price
- PCRX $28.38
- CYH $4.27
- AVG Volume (30 Days)
- PCRX 492.0K
- CYH 2.2M
- Earning Date
- PCRX 07-29-2025
- CYH 07-23-2025
- Dividend Yield
- PCRX N/A
- CYH N/A
- EPS Growth
- PCRX N/A
- CYH N/A
- EPS
- PCRX N/A
- CYH N/A
- Revenue
- PCRX $702,772,000.00
- CYH $12,653,000,000.00
- Revenue This Year
- PCRX $7.92
- CYH N/A
- Revenue Next Year
- PCRX $11.02
- CYH $3.49
- P/E Ratio
- PCRX N/A
- CYH N/A
- Revenue Growth
- PCRX 3.08
- CYH 1.05
- 52 Week Low
- PCRX $11.16
- CYH $2.24
- 52 Week High
- PCRX $27.64
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- PCRX 36.58
- CYH 58.67
- Support Level
- PCRX $22.23
- CYH $3.44
- Resistance Level
- PCRX $23.91
- CYH $3.64
- Average True Range (ATR)
- PCRX 0.82
- CYH 0.17
- MACD
- PCRX -0.01
- CYH 0.04
- Stochastic Oscillator
- PCRX 22.03
- CYH 75.25
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.